ストックスクリーナーアプリを入手
36.64
2.12%
0.76
プレマーケット:
37.22
0.58
+1.58%
前日終値:
$35.88
開ける：
$36.28
24時間の取引高:
467.00K
Relative Volume:
1.00
時価総額：
$1.10B
収益：
$1.37B
当期純損益:
$54.85M
株価収益率:
20.67
EPS:
1.7729
ネットキャッシュフロー:
$123.71M
1週間 パフォーマンス:
-0.41%
1か月 パフォーマンス:
+5.32%
6か月 パフォーマンス:
-17.55%
1年 パフォーマンス:
-35.69%
1日の値動き範囲:
$35.59
$36.86
1週間の範囲:
$35.10
$38.86
52週間の値動き範囲:
$33.21
$61.08
Conmed Corp Stock (CNMD) Company Profile
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
36.64 | 1.10B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | ダウングレード | Needham | Buy → Hold |
| 2025-04-28 | ダウングレード | Stifel | Buy → Hold |
| 2025-02-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-02-01 | 繰り返されました | Needham | Buy |
| 2023-05-22 | 開始されました | CL King | Buy |
| 2023-03-27 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | 開始されました | Wells Fargo | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-10-06 | アップグレード | Needham | Hold → Buy |
| 2021-07-15 | 開始されました | UBS | Buy |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2019-11-26 | ダウングレード | Needham | Buy → Hold |
| 2019-11-12 | 開始されました | JP Morgan | Overweight |
| 2019-10-31 | 繰り返されました | Needham | Buy |
| 2019-10-04 | 繰り返されました | Needham | Buy |
| 2019-08-22 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | 開始されました | Stifel | Buy |
| 2019-04-16 | 繰り返されました | Needham | Buy |
| 2019-01-23 | 繰り返されました | Needham | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-08-07 | 繰り返されました | Needham | Buy |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-04-26 | 繰り返されました | Needham | Buy |
| 2018-02-01 | 繰り返されました | Needham | Buy |
| 2017-07-27 | 繰り返されました | Needham | Buy |
| 2017-04-27 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | 繰り返されました | Needham | Buy |
| 2016-11-18 | 繰り返されました | Needham | Buy |
| 2016-07-28 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | 繰り返されました | Needham | Buy |
| 2015-10-22 | 繰り返されました | Northland Capital | Market Perform |
すべてを表示
Conmed Corp (CNMD) 最新ニュース
Oppenheimer Asset Management Inc. Has $1.27 Million Stock Holdings in CONMED Corporation $CNMD - MarketBeat
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance - Yahoo Finance
Is CONMED Corporation (CNMD) A Good Stock To Buy Now? - Yahoo Finance
CONMED (NYSE:CNMD) Stock Rating Lowered by Wall Street Zen - MarketBeat
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms - Yahoo Finance
Healthcare Momentum Story Meets NYSE Composite Trends - Kalkine Media
CONMED (NYSE:CNMD) Price Target Lowered to $39.00 at Wells Fargo & Company - MarketBeat
CNMD SEC FilingsConmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Conmed (CNMD) Q1 2026 Earnings Transcript - AOL.com
CONMED Corporation (NYSE:CNMD) Q1 2026 Earnings Call Transcript - Insider Monkey
CONMED (NYSE:CNMD) Price Target Lowered to $40.00 at JPMorgan Chase & Co. - MarketBeat
CONMED Corp 1Q 2026: Revenue $317M, EPS $0.45— 10-Q Summary - TradingView
CONMED (NYSE: CNMD) boosts Q1 2026 profit as margins expand - Stock Titan
CONMED Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up - Yahoo Finance
Conmed Corp (CNMD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Capitalizing on ... By GuruFocus - Investing.com Canada
CONMED Q1 Earnings Call Highlights - MarketBeat
CONMED (NYSE:CNMD) Releases Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steady - ChartMill
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED ($CNMD) Releases Q1 2026 Earnings - Quiver Quantitative
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
CONMED Q1 2026 slides: organic growth rises as GI exit weighs - Investing.com
Earnings call transcript: CONMED beats Q1 2026 forecasts, stock dips - Investing.com
Vanguard reports 1.62M shares in CONMED (NASDAQ: CNMD) as of 03/31/2026 - Stock Titan
CONMED’s (NYSE:CNMD) Q1 CY2026 Sales Beat Estimates - Barchart.com
Conmed: Q1 Earnings Snapshot - Barchart.com
Q1 2026: CONMED (NYSE: CNMD) lifts 2026 sales outlook, EPS $0.45 - Stock Titan
Medical device maker CONMED cut sales but raised its 2026 forecast - Stock Titan
Vanguard Portfolio Management (CNMD) reports 2.12M shares; 6.87% stake - Stock Titan
CONMED earnings on deck: Can AirSeal stabilize amid pressure? - Investing.com
Here's why you should retain CONMED stock in your portfolio now - MSN
CONMED Earnings: What To Look For From CNMD - Yahoo Finance
CONMED (CNMD) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Tributary Capital Management LLC Boosts Stock Position in CONMED Corporation $CNMD - MarketBeat
Is CONMED Stock Worth Watching Right Now - Kalkine Media
CONMED Corp stock (US2074101013): Is its surgical device leadership strong enough to unlock new upsi - AD HOC NEWS
How Conmed Corp.Ordinary Shares (CNMD) Affects Rotational Strategy Timing - Stock Traders Daily
CONMED Corporation (NYSE:CNMD) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Conmed Corp (CNMD) Stock Down 3.9% -- Now Undervalued? GF Score: 79/100 - GuruFocus
A Look at Conmed Corp (CNMD) After 3.3% Gain -- GF Value $78.09 vs Price $39.73 - GuruFocus
CONMED (NYSE:CNMD) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Conmed Corp (CNMD) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.93%
大文字化:
|
ボリューム (24 時間):